Home / Inspections / 1234681

FDA Inspection 1234681 — MedStar Georgetown Medical Center Inc Georgetown University Hospital

MedStar Georgetown Medical Center Inc Georgetown University Hospital — FEI 1174826

The FDA completed an inspection of MedStar Georgetown Medical Center Inc Georgetown University Hospital on March 18, 2024 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Washington, DC (United States)

Facility

Other inspections at this facility

  • 1107397 (NAI Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008520 (NAI Fri Mar 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923807 (VAI Mon Apr 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 826516 (NAI Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 777775 (VAI Thu Apr 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources